Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 10Unknown 2Terminated 2Withdrawn 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Dermatologic 2

Conditions

Melanoma 312Carcinoma, Basal Cell 60Skin Neoplasms 52Lymphoma, T-Cell, Cutaneous 37Breast Neoplasms 31Uveal Melanoma 29Neoplasms 27Lung Neoplasms 27Carcinoma, Non-Small-Cell Lung 27Keratosis, Actinic 25Neoplasm Metastasis 24Carcinoma, Squamous Cell 22Carcinoma, Renal Cell 21Lymphoma 17Mycosis Fungoides 16Lymphoma, Large B-Cell, Diffuse 15Hodgkin Disease 15Urinary Bladder Neoplasms 14Sezary Syndrome 14Pancreatic Neoplasms 14Lymphoma, Non-Hodgkin 14Lymphoma, Follicular 14Leukemia, Lymphocytic, Chronic, B-Cell 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Ovarian Neoplasms 13Lymphoma, Mantle-Cell 13Lymphoma, B-Cell, Marginal Zone 13Colorectal Neoplasms 13Burkitt Lymphoma 13Lymphoma, Large-Cell, Immunoblastic 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Non-melanoma Skin Cancer × Dermatologic × Clear all
NCT05550766 2022-09-22

Prognostic Value of RXR-α in Cutaneous Squamous and Basal Cell Carcinoma

Sohag University

Unknown
50 enrolled
Dermatologic

Non-melanoma Skin Cancer

NCT04103658 2019-09-25

NIR and Skin Cancer Margins

Western University, Canada

Phase NA Unknown
20 enrolled
Dermatologic

Non-melanoma Skin Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡